Perrigo | PRGO - Operating Expenses



Perrigo reported $1B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
AbbVie USD 9.71B 96M Jun/2025
Abbott USD 9.07B 369M Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Corcept Therapeutics USD 167.76M 13.96M Jun/2025
Dr.Reddys Laboratories INR 67.98B 1.88B Jun/2025
Eli Lilly USD 8.54B 1.22B Jun/2025
J&J USD 16.8B 8.54B Jun/2025
Merck USD 9.44B 217M Jun/2025
Nestle CHF 37.09B 1.94B Jun/2025
Pacira USD 170.87M 3.93M Jun/2025
Perrigo USD 1B 36.2M Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
Prestige Brands USD 177.77M 30.32M Jun/2025
Reckitt Benckiser GBP 6.26B 3.51B Dec/2024
Sanofi EUR 9.02B 702M Jun/2025
Supernus Pharmaceuticals USD 153.31M 892K Jun/2025
Teva Pharmaceutical Industries USD 3.28B 95M Jun/2025
Xeris Pharmaceuticals USD 67.06M 8.64M Jun/2025
Zoetis USD 1.44B 35M Jun/2025